(Q41725494)

8 October 2017

1 reference

title

Neurologic paraneoplastic syndromes (English)

1 reference

8 October 2017

Dropcho EJ

1

1 reference

8 October 2017

1 January 1998

1 reference

Journal of the Neurological Sciences

8 October 2017

1 reference

8 October 2017

153

1 reference

8 October 2017

2

1 reference

8 October 2017

264-278

1 reference

The occurrence of serum autoantibodies against enolase in cancer-associated retinopathy.

8 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

Paraneoplastic temporal lobe epilepsy with testicular neoplasm and atypical amnesia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

Paraneoplastic cerebellar degeneration: clinical-immunological correlations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

Limbic encephalitis and immunological perturbations in two patients with thymoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

Effects of intravenous immunoglobulin on muscle weakness and calcium-channel autoantibodies in the Lambert-Eaton myasthenic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

Paraneoplastic limbic encephalitis: clinico-pathological correlations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

Stiffman syndrome: a rare paraneoplastic disorder?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

Autoimmune paraneoplastic cerebellar degeneration in ovarian carcinoma patients treated with plasmapheresis and immunoglobulin: A case report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

Nova, the paraneoplastic Ri antigen, is homologous to an RNA-binding protein and is specifically expressed in the developing motor system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

The onconeural antigen Nova-1 is a neuron-specific RNA-binding protein, the activity of which is inhibited by paraneoplastic antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

Response of the Lambert-Eaton myasthenic syndrome to treatment of associated small-cell lung carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

Therapy for paraneoplastic neurologic syndromes in six patients with protein A column immunoadsorption

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

Paraneoplastic cerebellar degeneration. III. Cerebellar degeneration, cancer, and the Lambert-Eaton myasthenic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

Reversal of subacute paraneoplastic cerebellar syndrome with intravenous immunoglobulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

Detection of the anti-Hu antibody in specific regions of the nervous system and tumor from patients with paraneoplastic encephalomyelitis/sensory neuronopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

Neurologic paraneoplastic antibodies (anti-Yo; anti-Hu; anti-Ri): the case for a nomenclature based on antibody and antigen specificity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

Major histocompatibility proteins, anti-Hu antibodies, and paraneoplastic encephalomyelitis in neuroblastoma and small cell lung cancer

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Autoimmunity in stiff-Man syndrome with breast cancer is targeted to the C-terminal region of human amphiphysin, a protein similar to the yeast proteins, Rvs167 and Rvs161

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

The synaptic vesicle-associated protein amphiphysin is the 128-kD autoantigen of Stiff-Man syndrome with breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

Cloning of a brain protein identified by autoantibodies from a patient with paraneoplastic cerebellar degeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

Antineuronal (anti-Ri) antibodies in a patient with steroid-responsive opsoclonus-myoclonus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

Autoantibodies against the Hel-N1 RNA-binding protein among patients with lung carcinoma: an association with type I anti-neuronal nuclear antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

Antiamphiphysin antibodies with small-cell lung carcinoma and paraneoplastic encephalomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

Anti-Hu antibody in a neuroblastoma-associated paraneoplastic syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

Autoantibodies to a 128-kd synaptic protein in three women with the stiff-man syndrome and breast cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

Selective expression of Purkinje-cell antigens in tumor tissue from patients with paraneoplastic cerebellar degeneration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

Effect of intraventricular injection of an anti-Purkinje cell antibody (anti-Yo) in a guinea pig model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

Plasmapheresis and antineoplastic treatment in CNS paraneoplastic syndromes with antineuronal autoantibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

Indolent anti-Hu-associated paraneoplastic sensory neuropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

Type IIa ('anti-Hu') antineuronal antibodies produce destruction of rat cerebellar granule neurons in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

Uptake of systemically administered human anticerebellar antibody by rat Purkinje cells following blood-brain barrier disruption

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

Heterogeneity of autoantibodies in stiff-man syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

The proteins synaptotagmin and syntaxin are not general targets of Lambert-Eaton myasthenic syndrome autoantibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

Paraneoplastic cerebellar degeneration: a clinical comparison of patients with and without Purkinje cell cytoplasmic antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

Paraneoplastic cerebellar degeneration. II. Clinical and immunologic findings in 21 patients with Hodgkin's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

Paraneoplastic opsoclonus-myoclonus associated with anti-Hu antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

Gynecologic cancer in patients with subacute cerebellar degeneration predicted by anti-Purkinje cell antibodies and limited in metastatic volume.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

Ultrastructural localization of anti-Purkinje cell antibody-binding sites in paraneoplastic cerebellar degeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

Poor outcome in patients with advanced stage neuroblastoma and coincident opsomyoclonus syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

Antibodies to a subpopulation of glial cells and a 66 kDa developmental protein in patients with paraneoplastic neurological syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

Immunological and pathological study of anti-Ri-associated encephalopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

Nuclear localization of anti-Hu antibody is not associated with in vitro cytotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

The electrodiagnosis of myasthenia gravis and the Lambert-Eaton myasthenic syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

A clinical triad to diagnose paraneoplastic retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

Analysis of the IgG subclass distribution and inflammatory infiltrates in patients with anti-Hu-associated paraneoplastic encephalomyelitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

Heterogeneity of calcium channel autoantibodies detected using a small-cell lung cancer line derived from a Lambert-Eaton myasthenic syndrome patient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

Severe course of cutaneous melanoma associated paraneoplastic retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

Cutaneous melanoma-associated retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

Expression of Hel-N1 and Hel-N2 in small-cell lung carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

Mammalian homologs of Drosophila ELAV localized to a neuronal subset can bind in vitro to the 3' UTR of mRNA encoding the Id transcriptional repressor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

Magnetic resonance imaging of limbic encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

Paraneoplastic autoantibodies: the case for a descriptive generic nomenclature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

The synaptic vesicle protein synaptotagmin associates with calcium channels and is a putative Lambert-Eaton myasthenic syndrome antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

Paraneoplastic Encephalomyelitis Antigens Bind to the AU-rich Elements of mRNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

Anti-Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

Hu antigens: Reactivity with hu antibodies, tumor expression, and major immunogenic sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

3,4-Diaminopyridine in the treatment of Lambert-Eaton myasthenic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

Lambert-Eaton myasthenic syndrome immunoglobulins react with multiple types of calcium channels in small-cell lung carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

Opsoclonus-ataxia due to childhood neural crest tumors: a chronic neurologic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

Guidelines on the detection of paraneoplastic anti-neuronal-specific antibodies: report from the Workshop to the Fourth Meeting of the International Society of Neuro-Immunology on paraneoplastic neurological disease, held October 22-23, 1994, in Rot

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

An improved diagnostic assay for Lambert-Eaton myasthenic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

The Lambert-Eaton myasthenic syndrome. A review of 50 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

Cross-linking of presynaptic calcium channels: a mechanism of action for Lambert-Eaton myasthenic syndrome antibodies at the mouse neuromuscular junction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

Paraneoplastic cerebellar degeneration. I. A clinical analysis of 55 anti-Yo antibody-positive patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

A photoreceptor calcium binding protein is recognized by autoantibodies obtained from patients with cancer-associated retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

Recoverin, a photoreceptor-specific calcium-binding protein, is expressed by the tumor of a patient with cancer-associated retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

Selective immunohistochemical staining in the paraneoplastic retinopathy syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

Isolation of a complementary DNA clone encoding an autoantigen recognized by an anti-neuronal cell antibody from a patient with paraneoplastic cerebellar degeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

Analysis of autoantibody binding to 52-kd paraneoplastic cerebellar degeneration-associated antigen expressed in recombinant proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

Immunization with the paraneoplastic encephalomyelitis antigen HuD does not cause neurologic disease in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

Immunological and clinical response to immunosuppressive treatment in paraneoplastic cerebellar degeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

Limbic encephalitis occurring in association with Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

HuD, a paraneoplastic encephalomyelitis antigen, contains RNA-binding domains and is homologous to Elav and Sex-lethal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

Synaptotagmin can cause an immune-mediated model of Lambert-Eaton myasthenic syndrome in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

Antibodies to recombinant synaptotagmin and calcium channel subtypes in Lambert-Eaton myasthenic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

Passive transfer and active immunization with the recombinant leucine-zipper (Yo) protein as an attempt to establish an animal model of paraneoplastic cerebellar degeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

Clinical outcome in children with acute cerebellar encephalopathy and neuroblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

Antibody reactions with retina and cancer-associated antigens in 10 patients with cancer-associated retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

Paraneoplastic cerebellar degeneration and limbic encephalitis in a patient with adenocarcinoma of the colon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

P-type voltage-dependent calcium channel mediates presynaptic calcium influx and transmitter release in mammalian synapses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

Intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with antineuronal autoantibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

Intrathecal synthesis of the anti-Hu antibody in patients with paraneoplastic encephalomyelitis or sensory neuronopathy: clinical-immunologic correlation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

Inhibition of calcium currents and exocytosis by Lambert-Eaton syndrome antibodies in human lung cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

Paraneoplastic retinopathy associated with antiretinal bipolar cell antibodies in cutaneous malignant melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

Anti-Hu-associated peripheral nerve and muscle microvasculitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900296-7

10.1016/S0022-510X(97)00296-7

7 January 2021

Identifiers

DOI

1 reference

8 October 2017

1 reference

PubMed ID

9511883